K-numberK243618
Device nameEasiSlush® Sodium Chloride Solution for Sterile Slush Preparation (BTLE-1250)
ApplicantBridge TO Life
Product codeKDN
Device classClass II
Decision dateJun 17, 2025
DecisionSubstantially Equivalent
Regulation876.5880
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

EasiSlush® Sodium Chloride Solution for Sterile Slush Preparation is a 0.9% sodium chloride solution in a 2L sterile, non-PVC bag used to create and maintain hypothermia (cooling) of donor organs during recovery, storage, and transport for transplantation. It is also indicated for topical cooling during open surgical procedures such as cardiovascular, abdominal, and transplant surgeries to reduce metabolic activity and protect tissues during periods of ischemia.

Technological characteristics

The subject device is identical to the predicate in all technological characteristics: same 0.9% buffered sodium chloride solution, 300 mOsmol/kg osmolality, pH 4.5-7.0, 1,250 mL volume, single-use PVC-free bag with overwrap, terminal gamma irradiation sterilization, 24-month shelf life, and storage at 2-25°C with pre-cooling to -4 to -15°C before use. No changes to formulation, packaging, sterilization method, or mode of action.

Test standards cited

ISO 10993-1/2/5/10/12 (biocompatibility); USP monograph for 0.9% Sodium Chloride Irrigation.

Substantial equivalence argument

The indications for use were expanded to include surgical procedures (open heart and kidney surgery) in addition to organ recovery and storage/transport, but the mechanism of action—topical cooling to induce hypothermia and reduce metabolic activity—remains unchanged. Because there are no new technological characteristics, no changes to the device's formulation or design, and the expanded use operates under the same physiological principle as the original organ transplant applications, the submission argues the new indication does not raise new safety or effectiveness questions and therefore remains substantially equivalent to the predicate K191006 cleared in 2019.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →